HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL SUPPORT IN FIRST LINE TREATMENT OF AGGRESSIVE NON HODGKIN LYMPHOMA: RESULTS OF AN INDIVIDUAL PATIENT DATA META-ANALYSIS

被引：0
|
作者：
Brillant, C. [1 ]
Schwarzer, G. [2 ]
Bohlius, J. [3 ]
Greb, A. [1 ]
Trelle, S. [3 ]
Haioun, C. [4 ]
De Souza, A. [5 ]
Gisselbrecht, C. [6 ]
Intragumtornchai, T. [7 ]
Kaiser, U. [8 ]
Kluin-Nelemans, C. [9 ]
Martelli, M. [10 ]
Milpied, N. [11 ]
Verdonck, F. [12 ]
Vitolo, U. [13 ]
Engert, A. [14 ]
Schulz, H. [14 ]
机构：
[1] Cochrane Hematol Malignancies Grp, Cologne, Germany
[2] German Cochrane Ctr, Dept Med Biometry & Stat, Freiburg, Germany
[3] Inst Social & Prevent Med, Bern, Switzerland
[4] Hop Henri Mondor, Lymphoid Malignancies Unit, F-94010 Creteil, France
[5] Univ Estadual Campinas, Campinas, SP, Brazil
[6] Hosp St Louis, INSERM, U728, Dept Hematol Oncol, Paris, France
[7] Chulalongkorn Univ, Div Hematol, Dept Med, Bangkok, Thailand
[8] St Bernward Hosp, Dept Hematol, Hildesheim, Germany
[9] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, NL-9713 AV Groningen, Netherlands
[10] Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy
[11] Hop Haut Eveque, Serv Malad Sang, Bordeaux, France
[12] Isala Clin, Zwolle, Netherlands
[13] Univ San Giovanni Battista, Sect Hematol, Dept Oncol, Turin, Italy
[14] Univ Hosp Cologne, Cochrane Hematol Malignancies Grp, Cologne, Germany
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0974
引用
收藏
页码：392 / 392
页数：1
相关论文
共 50 条
  • [41] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA
    VOSE, JM
    ANDERSON, JR
    KESSINGER, A
    BIERMAN, PJ
    COCCIA, P
    REED, EC
    GORDON, B
    ARMITAGE, JO
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) : 1846 - 1851
  • [42] Toxicities Associated with High Dose Chemotherapy and Autologous Stem Cell Transplantation in Older Patients with Non-Hodgkin Lymphoma
    Dahi, Parastoo B.
    Clavo, Carlos Rondon
    Maloy, Molly
    Seier, Kenneth
    Devlin, Sean M.
    Robinson, Kevin
    Scordo, Michael
    Shah, Gunjan L.
    Tamari, Roni
    Matasar, Matthew J.
    Hamlin, Paul
    Jakubowski, Ann A.
    Sauter, Craig S.
    Moskowitz, Craig H.
    Giralt, Sergio A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S130 - S130
  • [43] High-dose sequential chemotherapy (HDSC) in support of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)
    Oyan, B
    Koc, Y
    Ozdemir, E
    Kansu, E
    BLOOD, 2004, 104 (11) : 393B - 393B
  • [44] High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma:: results of a multicenter phase II study
    Josting, A
    Sieniawski, M
    Glossmann, JP
    Staak, O
    Nogova, L
    Peters, N
    Mapara, M
    Dörken, B
    Ko, Y
    Metzner, B
    Kisro, J
    Diehl, V
    Engertl, A
    ANNALS OF ONCOLOGY, 2005, 16 (08) : 1359 - 1365
  • [45] High-dose Chemotherapy (HDC) with rituximab and autologous stem cell support in patients with poor prognosis non-Hodgkin's lymphoma (NHL)
    Ptushkin, V
    Mheidze, D
    Larionova, V
    Zukov, N
    Andreeva, L
    Osmanov, E
    Chimishkyan, K
    BONE MARROW TRANSPLANTATION, 2002, 29 : S95 - S95
  • [46] The efficiency of autologous stem cell transplantation as the first-line treatment for nodal peripheral T-cell lymphoma: results of a systematic review and meta-analysis
    Zhai, Yixin
    Wang, Jinhuan
    Jiang, Yanan
    Wu, Wenqi
    Lv, Yangyang
    Xu, Hong
    Tian, Linyan
    Sun, Huimeng
    Zhao, Zhigang
    Li, Lanfang
    EXPERT REVIEW OF HEMATOLOGY, 2022, 15 (03) : 265 - 272
  • [47] Long-term results of a phase-I/II study of sequential high-dose chemotherapy with autologous stem cell transplantation in the initial treatment of aggressive non-Hodgkin's lymphoma
    Welt, Anja
    Schiitt, Philipp
    Derks, Cordula
    Ebeling, Peter
    Muller, Siemke
    Metz, Klaus
    Anhuf, Juergen
    Moritz, Thomas
    Seeber, Siegfried
    Nowrousian, Mohammad Resa
    TUMORI JOURNAL, 2007, 93 (05): : 409 - 416
  • [48] A Single-Centre Analysis by Intention to Treat with High Dose Chemotherapy and Autologous Stem Cell Rescue Following Second-Line Treatment In Patients with Hodgkin Lymphoma
    Greaves, Paul
    Wilson, Andrew
    Matthews, Janet
    Brown, Daniel L. P.
    Montoto, Silvia
    Gribben, John G.
    Lister, Andrew
    BLOOD, 2010, 116 (21) : 989 - 990
  • [49] Complete response induced by fotemustine given as single agent in a patient with primary central nervous system non-Hodgkin aggressive lymphoma relapsed after high-dose chemotherapy and autologous stem cell support
    Pennese, Elsa
    Vergine, Carolina
    Matera, Rosella
    Dargenio, Michela
    Forese, Pasquale
    Di Renzo, Nicola
    LEUKEMIA & LYMPHOMA, 2011, 52 (11) : 2188 - 2189
  • [50] Autologous stem cell transplantation as consolidation treatment in aggressive non-Hodgkin's lymphoma patients in remission after conventional chemotherapy
    Sperotto, A
    Zaja, F
    Patriarca, F
    Silvestri, F
    Tiribelli, M
    Geromin, A
    Candoni, A
    Stocchi, R
    Damiani, D
    Fili, C
    Calistri, E
    Fanin, R
    BONE MARROW TRANSPLANTATION, 2003, 31 : S70 - S71
12345